Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
265 studies found for:    Open Studies | "Liver Cirrhosis"
Show Display Options
Rank Status Study
1 Recruiting Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
Condition: Liver Cirrhosis
Interventions: Drug: Entecavir;   Drug: Thymosin-α
2 Recruiting Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis
Condition: Liver Cirrhosis
Intervention: Biological: Mesenchymal Stem Cells
3 Recruiting Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Drug: ADSCs
4 Recruiting The Effect of Resistance Training on Muscle Strength and Nutritional Status in Patients With Liver Cirrhosis
Condition: Liver Cirrhosis
Interventions: Behavioral: Nutrition and strength training;   Behavioral: Nutrition
5 Recruiting Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis
Condition: Liver Cirrhosis
Interventions: Device: annual noncontrast MRI;   Device: biannual ultrasonography
6 Recruiting Cirrhosis, Effects of TRAnsplantation and Diabetes
Condition: Liver Cirrhosis
Intervention:
7 Recruiting SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy
Condition: Liver Cirrhosis, Alcoholic
Interventions: Behavioral: Supervised exercise;   Other: Usual Care;   Behavioral: SMS-messages
8 Recruiting Optimized Treatment and Regression of HBV-induced Early Cirrhosis
Condition: Liver Cirrhosis
Interventions: Drug: entecavir;   Drug: Thymosin-α
9 Recruiting Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis
Condition: Liver Cirrhosis
Intervention: Other: No relevant intervention.
10 Not yet recruiting Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis
Condition: Liver Cirrhosis
Interventions: Drug: Gabapentin;   Drug: Calcium Carbonate
11 Recruiting Boramae Hospital Liver Cirrhosis Patient Cohort Study
Conditions: Liver Cirrhosis;   Hepatocellular Carcinoma
Interventions: Procedure: Liver biopsy;   Device: Hepatic venous pressure gradient (HVPG) measurement
12 Recruiting Thrombin Generation Test in Patient With Liver Cirrhosis
Condition: Cirrhosis
Intervention:
13 Not yet recruiting Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic Cirrhosis
Condition: Liver Cirrhosis
Intervention: Other: (PSQI), (STQ).
14 Recruiting TIPS Combined With Variceal Embolization for the Prevention of Variceal Rebleeding in Patients With Cirrhosis
Condition: Liver Cirrhosis
Interventions: Procedure: TIPS;   Procedure: Embolization
15 Recruiting Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Interventions: Drug: Obeticholic Acid (OCA);   Drug: Placebo
16 Recruiting Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver Cirrhosis
Condition: Cirrhosis
Intervention:
17 Recruiting Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study
Conditions: Liver Cirrhosis;   Esophageal and Gastric Varices
Intervention: Procedure: Endoscopy
18 Recruiting Evaluating Ultrasound, Elastometry, Minilaparoscopy and Histology for the Diagnosis of Compensated Liver Cirrhosis.
Condition: Cirrhosis
Intervention: Procedure: ultrasound, liver elastometry, minilaparoscopy
19 Not yet recruiting Stem Cell Transplantation in Cirrhotic Patients
Condition: Liver Cirrhosis
Intervention: Biological: Mesenchymal stem cell transplantation
20 Not yet recruiting Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
Condition: Cirrhosis
Interventions: Other: Laboratory Biomarker Analysis;   Other: Placebo;   Drug: Simvastatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.